Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1991 1
2002 1
2003 1
2017 1
2018 1
2021 2
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

8 results

Results by year

Filters applied: . Clear all
Quoted phrase not found in phrase index: "Recurrent Ovarian Seromucinous Carcinoma"
Page 1
Extrauterine Mesonephric-like Carcinoma: A Comprehensive Single Institution Study of 33 Cases.
Euscher ED, Marques-Piubelli ML, Ramalingam P, Wistuba I, Lawson BC, Frumovitz M, Malpica A. Euscher ED, et al. Am J Surg Pathol. 2023 Jun 1;47(6):635-648. doi: 10.1097/PAS.0000000000002039. Epub 2023 Apr 6. Am J Surg Pathol. 2023. PMID: 37026792
Extrauterine mesonephric-like carcinoma (ExUMLC) shares histologic, immunohistochemical (IHC), and molecular (MOL) features with endometrial mesonephric-like carcinoma (EnMLC). ...Twenty-one ExUMLC (63%) had associated endometriosis, and 7 (21%) arose in a borderlin …
Extrauterine mesonephric-like carcinoma (ExUMLC) shares histologic, immunohistochemical (IHC), and molecular (MOL) features with endo …
Synchronous Occurrence of Ovarian Seromucinous Carcinoma and Endometrial Mucinous Carcinoma: A Case Report.
Urakawa R, Harada H, Tohyama A, Aoyama Y, Kinjo Y, Hoshino K, Ueda T, Kagami S, Tsukamoto J, Aoki T, Iwamura R, Hisaoka M, Matsuura Y, Yoshino K. Urakawa R, et al. J UOEH. 2021;43(2):235-242. doi: 10.7888/juoeh.43.235. J UOEH. 2021. PMID: 34092768 Free article.
Here we report a case of synchronous seromucinous carcinoma of the ovary and mucinous carcinoma of the endometrium with a literature review. ...The NAC was effective, and IDS was performed with no gross residual lesions. The post-operative diagnosis was se …
Here we report a case of synchronous seromucinous carcinoma of the ovary and mucinous carcinoma of the endometrium with …
Diagnostic criteria and behavior of ovarian seromucinous (endocervical-type mucinous and mixed cell-type) tumors: atypical proliferative (borderline) tumors, intraepithelial, microinvasive, and invasive carcinomas.
Shappell HW, Riopel MA, Smith Sehdev AE, Ronnett BM, Kurman RJ. Shappell HW, et al. Am J Surg Pathol. 2002 Dec;26(12):1529-41. doi: 10.1097/00000478-200212000-00001. Am J Surg Pathol. 2002. PMID: 12459620 Review.

Eight tumors (15%) with stromal invasion < or =5 mm were classified as microinvasive carcinoma. Seven tumors (13%) with either stromal invasion (five tumors) or micropapillary architecture measuring >5 mm (two tumors) were classified as carcinoma. ...Of the 29

…

Eight tumors (15%) with stromal invasion < or =5 mm were classified as microinvasive carcinoma. Seven tumors (13%) with either str

…
Prognostic similarity between ovarian mucinous carcinoma with expansile invasion and ovarian mucinous borderline tumor: A retrospective analysis.
Hada T, Miyamoto M, Ishibashi H, Matsuura H, Sakamoto T, Kakimoto S, Iwahashi H, Suzuki R, Sato K, Tsuda H, Takano M. Hada T, et al. Medicine (Baltimore). 2021 Aug 13;100(32):e26895. doi: 10.1097/MD.0000000000026895. Medicine (Baltimore). 2021. PMID: 34397915 Free PMC article.
There is a similarity of histological features and survival between ovarian mucinous carcinoma (MC) with expansile invasion and ovarian mucinous borderline tumor (MBT). The aim of this study was to compare the clinical outcomes of MC with expansile invasion w …
There is a similarity of histological features and survival between ovarian mucinous carcinoma (MC) with expansile invasion an …
Anaplastic carcinoma in ovarian seromucinous cystic tumor of borderline malignancy.
Okumura T, Muronosono E, Tsubuku M, Terao Y, Takeda S, Maruyama M. Okumura T, et al. J Ovarian Res. 2018 Sep 3;11(1):77. doi: 10.1186/s13048-018-0449-1. J Ovarian Res. 2018. PMID: 30176911 Free PMC article.
CASE PRESENTATION: We have reported a 53-year-old Japanese woman with anaplastic carcinoma in an ovarian seromucinous cystic tumor of borderline malignancy. ...To the best of our knowledge, this is the first study in English literature to report detailed clas …
CASE PRESENTATION: We have reported a 53-year-old Japanese woman with anaplastic carcinoma in an ovarian seromucinous c …
Morphologic Reproducibility, Genotyping, and Immunohistochemical Profiling Do Not Support a Category of Seromucinous Carcinoma of the Ovary.
Rambau PF, McIntyre JB, Taylor J, Lee S, Ogilvie T, Sienko A, Morris D, Duggan MA, McCluggage WG, Köbel M. Rambau PF, et al. Am J Surg Pathol. 2017 May;41(5):685-695. doi: 10.1097/PAS.0000000000000812. Am J Surg Pathol. 2017. PMID: 28125452
The goal of this study was to determine whether seromucinous carcinoma was a distinct histotype by assessing its diagnostic reproducibility and comparing its molecular composition to the 5 major histotypes of ovarian carcinoma. Thirty-two tumors diagno …
The goal of this study was to determine whether seromucinous carcinoma was a distinct histotype by assessing its diagnostic re …
The use of antioxidants with first-line chemotherapy in two cases of ovarian cancer.
Drisko JA, Chapman J, Hunter VJ. Drisko JA, et al. J Am Coll Nutr. 2003 Apr;22(2):118-23. doi: 10.1080/07315724.2003.10719284. J Am Coll Nutr. 2003. PMID: 12672707
OBJECTIVE: Because of poor overall survival in advanced ovarian malignancies, patients often turn to alternative therapies despite controversy surrounding their use. ...METHODS: For this preliminary report, two patients with advanced epithelial ovarian cancer were s …
OBJECTIVE: Because of poor overall survival in advanced ovarian malignancies, patients often turn to alternative therapies despite co …
Retroperitoneal lymphatic involvement with epithelial ovarian tumors of low malignant potential.
Leake JF, Rader JS, Woodruff JD, Rosenshein NB. Leake JF, et al. Gynecol Oncol. 1991 Aug;42(2):124-30. doi: 10.1016/0090-8258(91)90331-x. Gynecol Oncol. 1991. PMID: 1894170
This study was undertaken to evaluate retroperitoneal lymphatic involvement in patients with ovarian tumors of low malignant potential. One hundred seventy-one patients were diagnosed with epithelial ovarian tumors of low malignant potential between 1979 and 1989. . …
This study was undertaken to evaluate retroperitoneal lymphatic involvement in patients with ovarian tumors of low malignant potentia …